Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974078-23-000006
Filing Date
2023-05-08
Accepted
2023-05-08 17:38:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3880
  Complete submission text file 0001974078-23-000006.txt   5404
Mailing Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PKWY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2019, L.P. (Reporting) CIK: 0001845041 (see all company filings)

EIN.: 384092634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Subject) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41536 | Film No.: 23899152
SIC: 2836 Biological Products, (No Diagnostic Substances)